In immune cells, CEACAM1 has been reported to inhibit T-cell activation and inflammation [155], which postulates the idea that hepatic inflammation observed in CEACAM1-mutant mice may have resulted from the loss of CEACAM1’s anti-inflammatory effects. Here, CEACAM1 is linked to inflammation.